138 related articles for article (PubMed ID: 2803327)
21. Heterogeneity of C4d and C3d and their complex formation with serum albumin.
Petersen NE; Teisner B; Folkersen J; Svehag SE
Acta Pathol Microbiol Immunol Scand C; 1987 Aug; 95(4):129-35. PubMed ID: 3499750
[TBL] [Abstract][Full Text] [Related]
22. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
Tanaka C; Suhara Y; Kikkawa Y
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
[TBL] [Abstract][Full Text] [Related]
23. Factor B activation products in patients with systemic lupus erythematosus. A marker of severe disease activity.
Kerr LD; Adelsberg BR; Schulman P; Spiera H
Arthritis Rheum; 1989 Nov; 32(11):1406-13. PubMed ID: 2818657
[TBL] [Abstract][Full Text] [Related]
24. Activation of the complement system in primary sclerosing cholangitis.
Senaldi G; Donaldson PT; Magrin S; Farrant JM; Alexander GJ; Vergani D; Williams R
Gastroenterology; 1989 Dec; 97(6):1430-4. PubMed ID: 2583409
[TBL] [Abstract][Full Text] [Related]
25. Complement components in Nigerians with bronchial asthma.
Onyemelukwe GC
Ann Allergy; 1989 Oct; 63(4):309-12. PubMed ID: 2802267
[TBL] [Abstract][Full Text] [Related]
26. Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy.
Buyon JP; Tamerius J; Ordorica S; Young B; Abramson SB
Arthritis Rheum; 1992 Jan; 35(1):55-61. PubMed ID: 1731815
[TBL] [Abstract][Full Text] [Related]
27. Classical and alternative complement pathway activation in paracoccidioidomycosis.
de Messias IT; Mohren D
J Investig Allergol Clin Immunol; 1994; 4(2):91-5. PubMed ID: 7921333
[TBL] [Abstract][Full Text] [Related]
28. C3d and C4d deposition early after lung transplantation.
Westall GP; Snell GI; McLean C; Kotsimbos T; Williams T; Magro C
J Heart Lung Transplant; 2008 Jul; 27(7):722-8. PubMed ID: 18582800
[TBL] [Abstract][Full Text] [Related]
29. Activation of the classical complement pathway in spontaneous bacterial peritonitis.
Bird G; Senaldi G; Panos M; Rolando N; Alexander G; Vergani D; Williams R
Gut; 1992 Mar; 33(3):307-11. PubMed ID: 1568647
[TBL] [Abstract][Full Text] [Related]
30. Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes.
Baldwin WM; Samaniego-Picota M; Kasper EK; Clark AM; Czader M; Rohde C; Zachary AA; Sanfilippo F; Hruban RH
Transplantation; 1999 Sep; 68(6):894-900. PubMed ID: 10515392
[TBL] [Abstract][Full Text] [Related]
31. Complement activation and immune complexes in juvenile rheumatoid arthritis.
Jarvis JN; Pousak T; Krenz M; Iobidze M; Taylor H
J Rheumatol; 1993 Jan; 20(1):114-7. PubMed ID: 8441140
[TBL] [Abstract][Full Text] [Related]
32. Clinical application of new technique that measures C4d for assessment of activation of classical complement pathway.
Davies ET; Nasaruddin BA; Alhaq A; Senaldi G; Vergani D
J Clin Pathol; 1988 Feb; 41(2):143-7. PubMed ID: 3350977
[TBL] [Abstract][Full Text] [Related]
33. Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein.
Molenaar ET; Voskuyl AE; Familian A; van Mierlo GJ; Dijkmans BA; Hack CE
Arthritis Rheum; 2001 May; 44(5):997-1002. PubMed ID: 11352263
[TBL] [Abstract][Full Text] [Related]
34. Classical complement activation induced by pregnancy: implications for management of connective tissue diseases.
Hopkinson ND; Powell RJ
J Clin Pathol; 1992 Jan; 45(1):66-7. PubMed ID: 1740520
[TBL] [Abstract][Full Text] [Related]
35. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
Petersen NE; Elmgreen J; Teisner B; Svehag SE
Acta Med Scand; 1988; 223(6):557-60. PubMed ID: 3389208
[TBL] [Abstract][Full Text] [Related]
36. Molecular heterogeneity of second and fourth components of complement and their genes in systemic sclerosis and association of HLA alleles A1, B8 and DR3 with limited and DR5 with diffuse systemic sclerosis.
Venneker GT; van den Hoogen FH; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; Boerbooms AM; de Waal LP; Bos JD; Asghar SS
Exp Clin Immunogenet; 1998; 15(2):90-9. PubMed ID: 9691203
[TBL] [Abstract][Full Text] [Related]
37. Deficiency of complement-dependent prevention of immune precipitation in systemic sclerosis.
Arason GJ; Geirsson AJ; Kolka R; Víkingsdóttir T; Valdimarsson H
Ann Rheum Dis; 2002 Mar; 61(3):257-60. PubMed ID: 11830434
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of in vivo immune complex formation and complement activation in patients receiving intravenous streptokinase.
Freysdottir J; Ormarsdottir S; Sigfusson A
Clin Exp Immunol; 1993 Nov; 94(2):286-90. PubMed ID: 8222319
[TBL] [Abstract][Full Text] [Related]
39. [The in vitro inhibitory effect of sodium selenite on complement activation].
Li B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Jun; 13(3):195-8. PubMed ID: 1652384
[TBL] [Abstract][Full Text] [Related]
40. Assessment of the activation pathways of the complement in psoriatic patients by use of complement fragment C4d and Bb measurements.
Takematsu H; Tagami H
Dermatologica; 1989; 179 Suppl 1():16-9. PubMed ID: 2789155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
